Quantcast

Latest Esophageal cancer Stories

2014-05-20 08:26:56

NORWALK, Conn., May 20, 2014 /PRNewswire/ -- The Emmy Award-winning TV program The Doctors recently featured the case of "Jenny," a 29-year-old with severe gastroesophageal reflux disease (GERD). Jenny suffered for three years before she turned to University of California Irvine's Dr. Kenneth Chang for a solution in the form of Stretta(®) therapy. http://photos.prnewswire.com/prnvar/20130211/NY56794 Jenny had chronic GERD that was uncontrolled with medications and suffered from...

2014-05-19 23:05:05

Abington Memorial Hospital is pleased to announce Dr. Colleen Gaughan has joined Abington Memorial Hospital as a thoracic surgeon. Dr. Gaughan specializes in the treatment of lung and esophageal cancer, tumors of the mediastinum, chest wall and trachea, as well as all benign conditions of the chest, lungs, esophagus, chest wall and mediastinum. ABINGTON, PA (PRWEB) May 19, 2014 Abington Memorial Hospital is pleased to announce Dr. Colleen Gaughan has joined Abington Memorial Hospital as a...

2014-05-14 23:02:50

Jonathan Aviv MD, Clinical Director of the Ear, Nose, Throat, Allergy and Audiology Practice’s Voice and Swallowing Center, appears on the Dr. Oz TV Show discussing his new Acid Reflux book ‘Killing Me Softly From Inside’ Tarrytown, N.Y. (PRWEB) May 14, 2014 Voice and swallowing specialist Dr. Jonathan Aviv, MD, inventor and developer of the endoscopic air-pulse laryngeal sensory testing technology known as FEESST (Flexible Endoscopic Evaluation of Swallowing with Sensory Testing),...

2014-05-14 16:29:17

DecisionDx-Melanoma identifies patients with negative sentinel lymph node biopsies who are at high risk of metastasis FRIENDSWOOD, Texas, May 14, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced today that abstracts reporting additional clinical validation data for two of its molecular tests -- one focused on melanoma and the other on esophageal adenocarcinoma -- will be presented at the 50(th) Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30-June 3,...

2014-05-06 08:34:50

Enables physicians to pursue more effective treatment plans for patients who are chemoradiation resistant CHICAGO, May 6, 2014 /PRNewswire/ -- Castle Biosciences Inc. announced that data from two clinical validation studies of its DecisionDx-EC multi-biomarker test were reviewed in an oral presentation at the Digestive Disease Week (DDW) Annual Meeting. The data show that the test accurately predicts response to pre-surgical chemoradiation therapy (CTRT) in patients with esophageal...

2014-04-22 08:33:00

BETHESDA, Md., April 22, 2014 /PRNewswire-USNewswire/ -- The rate of developing esophageal squamous cell carcinoma (ESCC) nearly doubles in those who both smoke and drink compared to those who only smoke or drink, according to new research published in The American Journal of Gastroenterology. Although multiple studies have identified risk factors for the development of ESCC, notably, exposure to alcohol and tobacco, this research is the first meta-analysis to look at the interaction...

2014-04-03 12:30:00

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth SummaryGBI Research has released the pharma report "Monoclonal...

2014-03-26 08:28:35

Supplemental approval will expand PDT with Photofrin® treatments in specific lung and esophageal cancers TORONTO AND BANNOCKBURN, IL, March 26, 2014 /PRNewswire/ - Concordia Healthcare Corp. (Concordia or the Company) (TSX:CXR) (OTCQX: CHEHF) announced today that its subsidiary Pinnacle Biologics, Inc. (Pinnacle), a biopharmaceutical research and development company specializing in rare diseases, was granted U.S. Food and Drug Administration (FDA) premarket supplemental...

2014-03-22 20:20:22

Data presented at the Latest in Dermatology Research Symposia session of 72nd Annual Meeting of the American Academy of Dermatology DENVER, March 22, 2014 /PRNewswire/ -- Castle Biosciences Inc. today announced study results showing its gene expression profile (GEP) test (DecisionDx-Melanoma) can identify primary cutaneous (skin) melanoma tumors that are likely to metastasize in patients who had a negative sentinel lymph node biopsy. The data are being presented at the Latest in...

2014-02-24 12:26:21

Non-Surgical Procedure Offers Patients Significant Improvement in Symptoms and Elimination or Reduction in Medication, Along With a Regression of Barrett's Metaplasia NORWALK, Conn., Feb. 24, 2014 /PRNewswire/ -- A newly-published peer-reviewed clinical study evaluated 217 patients pre-treatment and tracked them for ten years after receiving Stretta Therapy to treat gastroesophageal reflux disease (GERD). The study, entitled "Long-term maintenance effect of radiofrequency energy delivery for...


Latest Esophageal cancer Reference Libraries

Gastroscopy
2013-03-04 10:13:56

The esophagogastroduodenoscopy is a medical diagnostic procedure used in internal medicine to view the upper part of the gastrointestinal tract. This non-invasive procedure is used for many complaints and requires little to no time for recovery from the procedure. Reasons for the Procedure Patients present to their physician with physical complaints. For example, a patient may come into the office and say they have been feeling tired and forgetful. Through many tests and evaluations,...

More Articles (1 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related